Breaking News

FDA Roundup: October 4, 2022 Strengthening Alliances in the Pacific – U.S. and Japan Conduct 15th Information Technology Forum Governor Cooper Proclaims October Cybersecurity Awareness Month, Warns of Hurricane-Related Scams Holland America Line's Special 150th Anniversary Crossing is a Celebration of the Brand's Journey Gov. Wolf Reminds Older Pennsylvanians of Upcoming 2023 Medicare Open Enrollment Period, Free Insurance Counseling Available through PA MEDI  Impacket and Exfiltration Tool Used to Steal Sensitive Information from Defense Industrial Base Organization CBP Officers Seize over $300,000 in Methamphetamine at the Eagle Pass Port of Entry Floodplain Management Educates Virgin Islanders on Flood Risk

Issued: London

GSK is delighted to have reached an agreement with the UK’s Department of Health that will enable babies in the UK to receive its meningitis B vaccine through the NHS immunisation schedule.

We have moved rapidly to conclude negotiations since we acquired the vaccine from Novartis at the beginning of March.

We believe the agreement we have reached offers fair value for the NHS and allows a reasonable return for GSK to ensure that we can continue to invest in creating new treatments and vaccines.

Source link